Lafayette, Colorado-based Front Range Biosciences, a cannabis biotech company, has raised $10 million in Series A financing. The investors included Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels and Altitude Investment Management.
Source: Press Release
Powered by WPeMatico
Comments are closed.